Stilbestrol Antibodies in Prostatic Cancer

  • Mark Silk


From the beginning of my urological residency I can recall Dr. Scott’s aversion to the routine maintenance of patients with prostatic carcinoma on diethylstilbestrol without specific indications. Subsequent studies by the Veterans Administration Cooperative Study Group have verified his earlier conclusions. This study suggests one additional possible difficulty that may be encountered in long-term diethylstilbestrol therapy.


Human Plasma Prostatic Carcinoma Antibody Formation Gonadal Steroid Paper Electrophoresis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Williams, R. H. The pancreas. In Textbook of Endocrinology, Williams, R. H. (ed.), W.B. Saunders Company, Philadelphia, 1968.Google Scholar
  2. 2.
    Desberg, D. Advanced prostatic carcinoma: Alteration of estrogen therapy. J. Urol. 83: 461, 1960.Google Scholar
  3. 3.
    Morales, P. A., Brendler, H., and Hotchkiss, R. Role of the adrenal cortex in prostatic carcinoma. J. Urol. 73: 399, 1955.PubMedGoogle Scholar
  4. 4.
    Rosner, W. Interaction of adrenal and gonadal steroids with proteins in human plasma. New Engl. J. Med. 281: 658, 1969.PubMedCrossRefGoogle Scholar
  5. 5.
    Rosner, W., and Deakins, S. M. Testosterone binding globulins in human plasma: Studies on sex distribution and specificity. J. Clin. Invest. 47: 2109, 1968.PubMedCrossRefGoogle Scholar
  6. 6.
    Vermeulen, A., and Verdonck, L. Studies on the binding of testosterone to human plasma. Steroids 11: 609, 1968.PubMedCrossRefGoogle Scholar
  7. 7.
    Campbell, D., Garvey, J. S., Cremer, N.E., and Sussdorf, D. H. (eds.), Immunology, W. A. Benjamin, Inc., New York, 1964.Google Scholar

Copyright information

© Plenum Press, New York 1972

Authors and Affiliations

  • Mark Silk
    • 1
  1. 1.Department of UrologyUniversity of Connecticut Medical SchoolHartfordUSA

Personalised recommendations